Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Abpro Holdings, Inc.ABP · Entity 8582 | Director · CEO and Chairman | July 31, 2025 | August 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Abpro Holdings, Inc.
Report date July 31, 2025 · Filed August 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 718,512 |
Reported balance
After 2025-07-31 transaction · row 1
1 source rowRow 1 · 2025-07-31 · Purchase · Acquired 72,035 · Balance 718,512 F1: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Abpro Holdings, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4. F2: These shares were purchased in multiple transactions at prices ranging from $0.2644 to $0.2979, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Abpro Holdings, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4.
F2: These shares were purchased in multiple transactions at prices ranging from $0.2644 to $0.2979, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2025 Filed Aug 4, 2025 17:22 UTC | Abpro Holdings, Inc. ABP · Entity 8582 | PurchaseCommon Stock, par value $0.0001 per share | 72,035 | $0.28 | $20,169.80 |
DisclosureSEC source: 0001474506-25-000146 · primary_doc.xml · nonDerivative · entry 1 Suk Jin Wook (Miles) · CIK 0002044498 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 718,512 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Abpro Holdings, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4. F2 · price: These shares were purchased in multiple transactions at prices ranging from $0.2644 to $0.2979, inclusive. Read SEC document |
| July 25, 2025 Filed Jul 29, 2025 08:42 UTC | Abpro Holdings, Inc. ABP · Entity 8582 | GrantCommon Stock, par value $0.0001 per share | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001474506-25-000143 · primary_doc.xml · nonDerivative · entry 1 Suk Jin Wook (Miles) · CIK 0002044498 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 646,477 F1 · balance_after: Certain of the securities reported in Column 5 of Table I are restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of common stock, par value $0.0001 per share, subject to the applicable vesting schedule and conditions of the applicable RSU award and the Issuer's 2024 Equity Incentive Plan. The 500,000 RSUs included in Column 5 of Table I vest in three equal annual installments on each anniversary of March 3, 2025, subject to BioCelsus International Inc.'s (the "Consultant") service continuing through and on each such vesting date. The RSUs were issued to the reporting person as the designee of the Consultant. Read SEC document |
| May 19, 2025 Filed May 19, 2025 20:37 UTC | Abpro Holdings, Inc. ABP · Entity 8582 | PurchaseCommon Stock, par value $0.0001 per share | 16,200 | $0.26 | $4,212.00 |
DisclosureSEC source: 0001474506-25-000098 · primary_doc.xml · nonDerivative · entry 1 Suk Jin Wook (Miles) · CIK 0002044498 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,477 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Abpro Holdings, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4. F2 · price: These shares were purchased in multiple transactions at prices ranging from $0.2580 to $0.2670, inclusive. Read SEC document |
| April 29, 2025 Filed May 1, 2025 16:21 UTC | Abpro Holdings, Inc. ABP · Entity 8582 | PurchaseCommon Stock, par value $0.0001 per share | 4,325 | $0.25 | $1,081.25 |
DisclosureSEC source: 0001474506-25-000077 · primary_doc.xml · nonDerivative · entry 1 Suk Jin Wook (Miles) · CIK 0002044498 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,277 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Abpro Holdings, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. F2 · price: These shares were sold in multiple transactions at prices ranging from $0.2482 to $0.2600, inclusive. Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 16:58 UTC | Abpro Holdings, Inc. ABP · Entity 8582 | PurchaseCommon Stock, par value $0.0001 per share | 26,542 | $0.34 | $9,024.28 |
DisclosureSEC source: 0001474506-25-000076 · primary_doc.xml · nonDerivative · entry 2 Suk Jin Wook (Miles) · CIK 0002044498 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,902 F1 · price: The prices reported in Column 4 are weighted average prices. The reporting person undertakes to provide to Abpro Holdings, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. F3 · price: These shares were sold in multiple transactions at prices ranging from $0.3224 to $0.3980, inclusive. Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 16:58 UTC | Abpro Holdings, Inc. ABP · Entity 8582 | PurchaseCommon Stock, par value $0.0001 per share | 7,460 | $0.28 | $2,088.80 |
DisclosureSEC source: 0001474506-25-000076 · primary_doc.xml · nonDerivative · entry 1 Suk Jin Wook (Miles) · CIK 0002044498 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,360 F1 · price: The prices reported in Column 4 are weighted average prices. The reporting person undertakes to provide to Abpro Holdings, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. F2 · price: These shares were sold in multiple transactions at prices ranging from $0.2517 to $0.2953, inclusive. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 21:34 UTC | Abpro Holdings, Inc. ABP · Entity 8582 | GrantCommon Stock, par value $0.0001 per share | 91,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001474506-24-000247 · primary_doc.xml · nonDerivative · entry 1 Suk Jin Wook (Miles) · CIK 0002044498 · Director · Co-CEO & Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,900 F1 · shares: Reflects the issuance by Abpro Holdings, Inc. (f/k/a Atlantic Coastal Acquisition Corp. II) (the "Issuer") on November 13, 2024, of an aggregate of 91,900 shares of Common Stock (the "Shares") pursuant to a Business Combination Agreement, dated as of December 11, 2023 (as amended by Amendment No. 1 to Business Combination Agreement, dated September 4, 2024, the "Business Combination Agreement"), among the Issuer, Abpro Merger Sub Corp, a Delaware corporation, and Abpro Corporation, a Delaware corporation ("Abpro"), relating to the business combination between the Issuer and Abpro (the "Business Combination"). The Shares are comprised of (1) 85,600 shares issued as merger consideration, and (ii) 6,300 shares issuable pursuant to rollover RSUs issued in connection with the Business Combination. Read SEC document |
| November 13, 2024 Filed Nov 25, 2024 21:58 UTC Amendment | Abpro Holdings, Inc. ABP · Entity 8582 | GrantStock option (right to buy) · Derivative | 613,500 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0001474506-24-000260 · primary_doc.xml · derivative · entry 1 Suk Jin Wook (Miles) · CIK 0002044498 · Director · Co-CEO & Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · By Biocelsus International Co. Ltd. Disclosed balance after: 613,500 Underlying: Common Stock, par value $0.0001 per share · 613,500 shares Expires 2032-02-18 F1 · shares: On November 15, 2024, the reporting person filed a Form 4 which inadvertently omitted the transaction disclosed hereby. F2 · shares: Reflects the issuance by Abpro Holdings, Inc. (f/k/a Atlantic Coastal Acquisition Corp. II) (the "Issuer") on November 13, 2024, of rollover stock option awards in connection with the business combination between the Issuer and Abpro Corporation, a Delaware corporation ("Abpro"), pursuant to a Business Combination Agreement, dated as of December 11, 2023 (as amended by Amendment No. 1 to Business Combination Agreement, dated September 4, 2024, the "Business Combination Agreement"), by and among the Issuer, Abpro Merger Sub Corp, a Delaware corporation, and Abpro. F3 · derivative.exercise_date: This stock option award is 100% vested. F4 · balance_after: Biocelsus International Co. Ltd. is controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.